Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), downbeat nystagmus and Tourette syndrome. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS, CMS and myasthenia gravis; CPP-115, a GABA aminotransferase inhibitor for central nervous system (CNS) indications, such as infantile spasms, epilepsy and Tourette syndrome; and CPP-109, a generic version of Sabril for Tourette’s disorder. Catalyst is headquartered in Coral Gables, Florida, the US.
Scope
- Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis
- An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments
- News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
ReceptoPharm Inc
Psyadon Pharmaceuticals Inc
Pfizer Inc
Marinus Pharmaceuticals Inc
Marathon Pharmaceuticals LLC
Jacobus Pharmaceutical Company
GlaxoSmithKline Plc
ReceptoPharm Inc
Psyadon Pharmaceuticals Inc
Pfizer Inc
Marinus Pharmaceuticals Inc
Marathon Pharmaceuticals LLC
Jacobus Pharmaceutical Company
GlaxoSmithKline Plc
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Catalyst Pharmaceuticals Inc ...
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Catalyst Pharmaceuticals Inc - Key Facts 6
Catalyst Pharmaceuticals Inc - Key Employees 7
Catalyst Pharmaceuticals Inc - Key Employee Biographies 8
Catalyst Pharmaceuticals Inc - Major Products and Services 9
Catalyst Pharmaceuticals Inc - History 10
Catalyst Pharmaceuticals Inc - Company Statement 12
Catalyst Pharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Catalyst Pharmaceuticals Inc - Business Description 15
Catalyst Pharmaceuticals Inc - Corporate Strategy 16
Catalyst Pharmaceuticals Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Catalyst Pharmaceuticals Inc - Strengths 17
Catalyst Pharmaceuticals Inc - Weaknesses 18
Catalyst Pharmaceuticals Inc - Opportunities 19
Catalyst Pharmaceuticals Inc - Threats 20
Catalyst Pharmaceuticals Inc - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Catalyst Pharmaceuticals Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Aug 07, 2018: Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update 31
Aug 06, 2018: Catalyst Pharmaceuticals expands commercial leadership team 33
May 23, 2018: CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease 34
May 09, 2018: Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update 35
Mar 14, 2018: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update 36
Nov 08, 2017: Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update 38
Oct 26, 2017: Catalyst Biosciences Announces the Appointment of Industry Veteran Andrea Hunt to its Board of Directors 39
Aug 09, 2017: Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update 40
May 10, 2017: Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update 42
Mar 15, 2017: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update 43
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
List of Tables
Catalyst Pharmaceuticals Inc, Key Facts 6
Catalyst Pharmaceuticals Inc, Key Employees 7
Catalyst Pharmaceuticals Inc, Key Employee Biographies 8
Catalyst Pharmaceuticals Inc, ...
List of Tables
Catalyst Pharmaceuticals Inc, Key Facts 6
Catalyst Pharmaceuticals Inc, Key Employees 7
Catalyst Pharmaceuticals Inc, Key Employee Biographies 8
Catalyst Pharmaceuticals Inc, Major Products and Services 9
Catalyst Pharmaceuticals Inc, History 10
Catalyst Pharmaceuticals Inc, Subsidiaries 13
Catalyst Pharmaceuticals Inc, Key Competitors 21
Catalyst Pharmaceuticals Inc, Ratios based on current share price 22
Catalyst Pharmaceuticals Inc, Annual Ratios 23
Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...1) 24
Catalyst Pharmaceuticals Inc, Interim Ratios 26
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Catalyst Pharmaceuticals Inc, Recent Deals Summary 30
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48
List of Figures
List of Figures
Catalyst Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25
Catalyst Pharmaceuticals Inc, Ratio Charts 27
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals ...
List of Figures
Catalyst Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25
Catalyst Pharmaceuticals Inc, Ratio Charts 27
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29